fenoldopam has been researched along with acetylcysteine in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 21 (80.77) | 29.6817 |
2010's | 5 (19.23) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Allaqaband, S; Bajwa, TK; Gupta, A; Malik, AM; Shalev, Y; Tumuluri, R; Volkert, P | 1 |
Brinker, JA | 1 |
Lepor, NE | 2 |
King, SL; Thompson, EJ | 1 |
Brokering, KL; Theobald, JC; Walker, PD | 1 |
Morcos, SK | 1 |
Asif, A; Epstein, M | 1 |
Airoldi, F; Balestrieri, P; Briguori, C; Castelli, A; Colombo, A; Focaccio, A; Golia, B; Lepore, S; Librera, M; Paolo Elia, P; Ricciardelli, B; Riviezzo, G; Scarpato, P; Violante, A | 1 |
Kellum, J; Leblanc, M; Venkataraman, R | 3 |
Itoh, Y; Oishi, R; Sendo, T; Yano, T | 1 |
Cieciorka, M; Ineck, BA; Kline, ME; Ng, TM; Nissen, LR; O'Leary, EL; Porter, LL; Puumala, SE; Rigmaiden, RS; Shurmur, SW; Silver, M | 1 |
de Fijter, C; Schultz, MJ; Smit, W; Tonino, S; van den Berk, G | 1 |
Kolarz, M; Sułowicz, W | 1 |
Pannu, N; Tonelli, M | 1 |
Mehran, R | 1 |
Dangas, G; Mehran, R; Pucelikova, T | 1 |
Barr, LF; Kolodner, K | 1 |
Kellum, JA; Leblanc, M; Venkataraman, R | 1 |
Caixeta, A; Mehran, R | 1 |
Corona, D; Cutuli, M; Molino, C; Morello, G; Pappalardo, R; Parrinello, L; Rinzivillo, D; Sorbello, M; Veroux, M; Veroux, P | 1 |
Nahl, D; Rundback, JH; Yoo, V | 1 |
Briguori, C; Condorelli, G; Donnarumma, E; Fiore, D; Quintavalle, C | 1 |
20 review(s) available for fenoldopam and acetylcysteine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and N-acetylcysteine.
Topics: Acetylcysteine; Animals; Contrast Media; Diabetes Complications; Dogs; Dopamine Agonists; Evaluation Studies as Topic; Fenoldopam; Fluid Therapy; Free Radical Scavengers; Humans; Ischemia; Kidney Diseases; Kidney Tubules; Models, Animal | 2003 |
Acetylcysteine and fenoldopam. Promising new approaches for preventing effects of contrast nephrotoxicity.
Topics: Acetylcysteine; Antioxidants; Contrast Media; Drug Administration Routes; Drug Administration Schedule; Fenoldopam; Humans; Renal Insufficiency; Risk Factors; Vasodilator Agents | 2003 |
A review of pharmacologic interventions to prevent contrast-induced nephropathy.
Topics: Acetylcysteine; Adenosine; Calcium Channel Blockers; Contrast Media; Creatinine; Fenoldopam; Furosemide; Hemodynamics; Humans; Kidney Diseases; Mannitol; Prostaglandins | 2003 |
Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy: a review.
Topics: Acetylcysteine; Contrast Media; Dopamine Agonists; Fenoldopam; Free Radical Scavengers; Humans; Ischemia; Kidney; Kidney Diseases; Randomized Controlled Trials as Topic | 2003 |
Prevention of contrast media nephrotoxicity--the story so far.
Topics: Acetylcysteine; Alprostadil; Atrial Natriuretic Factor; Contrast Media; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Fenoldopam; Hemofiltration; Humans; Kidney Diseases; Renal Dialysis; Risk Factors; Vasodilator Agents | 2004 |
Prevention of radiocontrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Contrast Media; Creatinine; Fenoldopam; Hemofiltration; Humans; Renal Dialysis; Ultrafiltration | 2004 |
Acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Aminoglycosides; Calcium Channel Blockers; Diuretics; Dopamine; Dopamine Agonists; Fenoldopam; Fluid Therapy; Humans; Mannitol; Renal Replacement Therapy; Theophylline | 2003 |
Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media.
Topics: Acetylcysteine; Acute Kidney Injury; Adenosine; Alprostadil; Animals; Apoptosis; Ascorbic Acid; Atrial Natriuretic Factor; Contrast Media; Diuretics; Endothelins; Epoprostenol; Fenoldopam; Fluid Therapy; Hemodiafiltration; Hemofiltration; Humans; Iodine Radioisotopes; Kidney Tubules; Models, Biological; Renal Dialysis; Risk Factors | 2005 |
Acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Aminoglycosides; Amphotericin B; Calcium Channel Blockers; Diuretics, Osmotic; Dopamine; Fenoldopam; Fluid Therapy; Humans; Mannitol; Natriuretic Peptides; Renal Dialysis; Renal Replacement Therapy; Sodium Potassium Chloride Symporter Inhibitors; Theophylline | 2005 |
Bench-to-bedside review: preventive measures for contrast-induced nephropathy in critically ill patients.
Topics: Acetylcysteine; Contrast Media; Critical Care; Fenoldopam; Free Radical Scavengers; Hemofiltration; Humans; Kidney Diseases; Sodium Bicarbonate; Theophylline; Treatment Outcome; Vasodilator Agents | 2005 |
[Nephropathy caused by radiocontrast media].
Topics: Acetylcysteine; Acute Kidney Injury; Clinical Trials as Topic; Contrast Media; Fenoldopam; Fluid Therapy; Hemodiafiltration; Hemofiltration; Humans; Isotonic Solutions; Kidney Tubules; Radiopharmaceuticals | 2005 |
Strategies to reduce the risk of contrast nephropathy: an evidence-based approach.
Topics: Acetylcysteine; Ascorbic Acid; Contrast Media; Evidence-Based Medicine; Fenoldopam; Humans; Kidney Diseases; Osmolar Concentration; Risk Factors; Theophylline | 2006 |
Renal failure (acute).
Topics: Acetylcysteine; Acute Kidney Injury; Aminoglycosides; Aminophylline; Amphotericin B; Calcium Channel Blockers; Diuretics, Osmotic; Dopamine; Fenoldopam; Fluid Therapy; Humans; Mannitol; Natriuretic Peptides; Renal Dialysis; Renal Replacement Therapy; Theophylline | 2006 |
Contrast-induced nephropathy remains a serious complication of PCI.
Topics: Acetylcysteine; Angioplasty, Balloon, Coronary; Contrast Media; Disease Progression; Fenoldopam; Humans; Incidence; Kidney Diseases; Prognosis; Risk Factors; Sodium Bicarbonate | 2007 |
Contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Calcium Channel Blockers; Contrast Media; Coronary Angiography; Creatinine; Diabetes Mellitus; Fenoldopam; Free Radical Scavengers; Heart Failure; Humans; Iatrogenic Disease; Kidney Diseases; Kidney Transplantation; Multivariate Analysis; Osmolar Concentration; Phosphodiesterase Inhibitors; Prognosis; Renal Dialysis; Risk Factors; Theophylline | 2008 |
Acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Fenoldopam; Humans; Renal Dialysis; Renal Insufficiency; Renal Replacement Therapy | 2008 |
Evidence-based management of patients undergoing PCI: contrast-induced acute kidney injury.
Topics: Acetylcysteine; Acute Disease; Angioplasty, Balloon, Coronary; Contrast Media; Dopamine; Drug Administration Routes; Evidence-Based Medicine; Fenoldopam; Fluid Therapy; Humans; Kidney Diseases; Patient Selection; Practice Guidelines as Topic; Protective Agents; Radiography, Interventional; Risk Assessment; Risk Factors; Sodium Bicarbonate; Treatment Outcome | 2010 |
Contrast-induced nephropathy.
Topics: Acetylcysteine; Antioxidants; Contrast Media; Evidence-Based Medicine; Fenoldopam; Fluid Therapy; Humans; Kidney Diseases; Risk Assessment; Risk Factors; Treatment Outcome; Vasodilator Agents | 2011 |
Therapeutic strategies to prevent contrast-induced acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Antioxidants; Calcium Channel Blockers; Contrast Media; Diuretics; Dopamine; Fenoldopam; Fluid Therapy; Furosemide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Length of Stay; Treatment Outcome; Vasodilator Agents | 2013 |
4 trial(s) available for fenoldopam and acetylcysteine
Article | Year |
---|---|
Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Contrast Media; Coronary Angiography; Creatinine; Female; Fenoldopam; Free Radical Scavengers; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Risk Factors; Sodium Chloride; Stroke Volume; Treatment Outcome | 2002 |
N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity.
Topics: Acetylcysteine; Administration, Oral; Aged; Contrast Media; Coronary Angiography; Coronary Artery Disease; Creatinine; Dopamine Agonists; Drug Administration Schedule; Female; Fenoldopam; Free Radical Scavengers; Humans; Infusions, Intravenous; Kidney Diseases; Male | 2004 |
Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN).
Topics: Acetylcysteine; Adult; Aged; Cardiac Catheterization; Contrast Media; Female; Fenoldopam; Humans; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Prospective Studies | 2006 |
N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery.
Topics: Acetylcysteine; Aged; Cardiac Surgical Procedures; Dopamine Agonists; Double-Blind Method; Female; Fenoldopam; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Postoperative Complications; Prospective Studies | 2008 |
2 other study(ies) available for fenoldopam and acetylcysteine
Article | Year |
---|---|
The third strike.
Topics: Acetylcysteine; Antihypertensive Agents; Cardiovascular Diseases; Contrast Media; Fenoldopam; Free Radical Scavengers; Humans; Kidney Diseases; Radiopharmaceuticals; Sodium Chloride | 2002 |
Effect of N-acetyl-cysteine (NAC) added to fenoldopam or dopamine on end-tidal carbon dioxide and mean arterial pressure at time of renal artery declamping during cadaveric kidney transplantation.
Topics: Acetylcysteine; Adult; Aged; Antihypertensive Agents; Antioxidants; Blood Pressure; Cadaver; Carbon Dioxide; Dopamine; Dopamine Agents; Female; Fenoldopam; Humans; Kidney Transplantation; Male; Middle Aged; Renal Artery; Retrospective Studies; Tidal Volume; Tissue Donors | 2010 |